1. Home
  2. TLX vs CSW Comparison

TLX vs CSW Comparison

Compare TLX & CSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLX
  • CSW
  • Stock Information
  • Founded
  • TLX 2015
  • CSW 2014
  • Country
  • TLX Australia
  • CSW United States
  • Employees
  • TLX N/A
  • CSW N/A
  • Industry
  • TLX Biotechnology: Pharmaceutical Preparations
  • CSW Home Furnishings
  • Sector
  • TLX Health Care
  • CSW Industrials
  • Exchange
  • TLX Nasdaq
  • CSW Nasdaq
  • Market Cap
  • TLX 5.7B
  • CSW 5.2B
  • IPO Year
  • TLX N/A
  • CSW N/A
  • Fundamental
  • Price
  • TLX $15.97
  • CSW $304.81
  • Analyst Decision
  • TLX Strong Buy
  • CSW Buy
  • Analyst Count
  • TLX 3
  • CSW 1
  • Target Price
  • TLX $22.33
  • CSW $320.00
  • AVG Volume (30 Days)
  • TLX 52.5K
  • CSW 123.8K
  • Earning Date
  • TLX 01-01-0001
  • CSW 07-30-2025
  • Dividend Yield
  • TLX N/A
  • CSW 0.35%
  • EPS Growth
  • TLX 798.14
  • CSW 28.53
  • EPS
  • TLX 0.09
  • CSW 8.38
  • Revenue
  • TLX $484,687,790.00
  • CSW $878,301,000.00
  • Revenue This Year
  • TLX N/A
  • CSW $22.74
  • Revenue Next Year
  • TLX N/A
  • CSW $7.24
  • P/E Ratio
  • TLX $173.46
  • CSW $36.27
  • Revenue Growth
  • TLX 55.85
  • CSW 10.78
  • 52 Week Low
  • TLX $13.61
  • CSW $249.84
  • 52 Week High
  • TLX $30.36
  • CSW $436.50
  • Technical
  • Relative Strength Index (RSI)
  • TLX N/A
  • CSW N/A
  • Support Level
  • TLX N/A
  • CSW N/A
  • Resistance Level
  • TLX N/A
  • CSW N/A
  • Average True Range (ATR)
  • TLX 0.00
  • CSW 0.00
  • MACD
  • TLX 0.00
  • CSW 0.00
  • Stochastic Oscillator
  • TLX 0.00
  • CSW 0.00

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

About CSW CSW Industrials Inc. Common Stock

CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.

Share on Social Networks: